Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
diabetic; have all my body issues; This serious case was reported by a consumer via interactive digital media and described the occurrence of diabetes in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 months after receiving Shingles vaccine, the patient experienced diabetes (Verbatim: diabetic) (serious criteria GSK medically significant) and discomfort bodily (Verbatim: have all my body issues). The outcome of the diabetes was not reported and the outcome of the discomfort bodily was not reported (duration 3 months). It was unknown if the reporter considered the diabetes and discomfort bodily to be related to Shingles vaccine. The company considered the diabetes to be unrelated to Shingles vaccine. It was unknown if the company considered the discomfort bodily to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 15-FEB-2026 This case was reported by a patient via interactive digital media. After Shingles vaccination, after 3 months had all his/her body issues plus diabetic. The batch number was not provided and we and unable to contact the reporter.; Sender's Comments: A case of Diabetes mellitus, 3 months after receiving Shingles vaccine, in a patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.